Retina (Philadelphia, Pa.)۲٬۰۲۵نمایه شده در PubMed
Jae Hui Kim, Yeji Kim, Sang Min Park, Han Joo Cho
چکیده
To evaluate the clinical outcomes of a treat-and-extend regimen using aflibercept for Type 3 macular neovascularization. In this prospective phase four clinical trial, 25 patients with Type 3 macular neovascularization underwent treat-and-extend with aflibercept for over 76 weeks. After an initial…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1097/iae.0000000000004571